Datametrex AI (TSXV: DM) continues to see positive cash flow from its growing operations in both the artificial intelligence and health industries. The firm this morning reported a substantial bump in its cash on hand since the last reporting period.
As of this morning, the company reportedly has approximately $20 million in cash and cash equivalents on its balance, as the company reported this morning. The figure is a significant improvement from the $11.1 million the firm recorded on its balance sheet as of September 30, 2021.
In per share terms, that cash figure works out to approximately $0.056 per share. The figure is due to continued positive cash flow from operations, a trend which the company has stated it believes will continue in 2022, with stronger cash flow expected for the current year.
Sponsored · First Phosphate Corp.
“We are pleased with the great start to the year as we continue to make every effort to improve revenue and find efficiencies from the efforts made over the years. We look forward to delivering on greater cash flow in 2022,” stated Marshall Gunter, CEO of Datametrex.
Datametrex last traded at $0.23 on the TSX Venture.
FULL DISCLOSURE: DataMetrex AI Limited is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover DataMetrex AI Limited on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. We may buy or sell securities in the company at any time. Always do additional research and consult a professional before purchasing a security.
